How Expensive Is Ozempic in 2026? Real Prices With and Without Insurance

Key Takeaways

• Without insurance, Ozempic costs $940 to $1,350 per month at major U.S. pharmacies in 2026.
• With commercial insurance, the typical copay range is $25 to $500 per month, depending on formulary tier, deductible status, and prior authorization.
• The Novo Nordisk savings card can reduce eligible commercial-insurance copays to as low as $25 per fill, with a maximum benefit of about $150.
• Medicare Part D copays for Ozempic typically run $200 to $500 monthly, and Medicare patients are not eligible for the savings card.
• Compounded semaglutide through online platforms runs $179 to $349 per month, the most common alternative for patients without coverage.

Direct answer (40-60 words)

Ozempic costs $940 to $1,350 per month without insurance and $25 to $500 per month with commercial insurance, depending on formulary tier and deductible status. Eligible patients with commercial insurance can use the Novo Nordisk savings card to pay as little as $25 per fill. Medicare patients typically pay $200 to $500 monthly and cannot use the savings card.

Table of contents

1. The 30-second answer
2. Ozempic cash price by pharmacy in 2026
3. Why Ozempic is so expensive in the first place
4. Insurance pricing: what determines your specific copay
5. The Novo Nordisk savings card: who qualifies, who does not
6. Medicare and Medicaid pricing
7. The Patient Assistance Program for low-income patients
8. Compounded semaglutide as a cash-pay alternative
9. How to find your actual cost in 5 minutes
10. The five most common cost surprises
11. FAQ

Ozempic cash price by pharmacy in 2026

Q1 2026 cash prices for a 1-month supply of Ozempic (any dose strength) at major U.S. pharmacies:

Pharmacy	Cash price	With GoodRx coupon	Membership required
Walmart	$940 to $1,150	$850 to $1,000	No
CVS	$1,025 to $1,200	$920 to $1,075	No
Walgreens	$1,000 to $1,180	$895 to $1,050	No
Rite Aid	$980 to $1,150	$880 to $1,025	No
Costco	$895 to $1,025	Built into price	Yes ($60+/yr)
Sam's Club	$920 to $1,050	Built into price	Yes ($50+/yr)
HEB	$950 to $1,100	$865 to $990	No
Mark Cuban Cost Plus Drugs	Does not stock brand Ozempic	N/A	No

Costco consistently has the lowest cash price among major chains for members. Walmart is the lowest non-membership cash price at most zip codes. Variation between pharmacies in the same zip code rarely exceeds $150 per fill.

The cash price is essentially the same across dose strengths. A 0.25 mg starter pen and a 2 mg high-dose pen cost the same to fill because the pharmacy and manufacturer charge per pen, not per milligram. This is unusual for prescription medications and is specific to GLP-1 pen products.

Why Ozempic is so expensive in the first place

Three factors drive the price.

Patent protection. Novo Nordisk holds patents on semaglutide and the Ozempic delivery device through the early 2030s in most markets. With no generic competition, Novo sets the wholesale acquisition cost (WAC) at whatever the market will pay. In 2026, the WAC for Ozempic in the U.S. is approximately $986 per month. Pharmacies mark this up modestly to reach the cash price.

Manufacturing complexity. Semaglutide is a peptide, not a small molecule. It requires complex synthesis, purification, and formulation. The pre-filled pen device adds cost on top of the drug itself. The combined manufacturing cost is higher than for a small-molecule pill, though not high enough to explain the full retail price.

Demand exceeding supply. From 2022 through early 2025, Ozempic and Wegovy were on the FDA drug shortage list. During the shortage, demand exceeded supply globally. Manufacturers had no commercial incentive to discount. Pharmacies had no incentive to price-match competitors because patients had limited options. By 2026 supply has stabilized but pricing has not corrected meaningfully because the patent still holds.

A 2024 analysis (Tu et al., JAMA Network Open 2024) compared U.S. Ozempic pricing to other high-income countries. The U.S. WAC of approximately $986 per month is roughly 5 to 10 times the price in Germany, France, and the UK, where single-payer or government-negotiated systems set prices closer to manufacturing cost plus margin.

Insurance pricing: what determines your specific copay

Four factors determine what you actually pay with insurance.

Factor 1: Your formulary tier. Insurance plans sort medications into tiers. Tier 1 is generics ($5 to $15). Tier 2 is preferred brands ($30 to $75). Tier 3 is non-preferred brands ($75 to $200). Tier 4 or specialty is injectables and high-cost drugs (20 to 40% coinsurance). Ozempic typically lands on Tier 3 or Tier 4 across most commercial plans. Some employer plans negotiate Tier 2 placement.

Factor 2: Your diagnosis. Ozempic is FDA-approved for type 2 diabetes. If your prescription is written for type 2 diabetes, your plan's diabetes coverage applies. If it is written off-label for weight loss, most plans deny coverage entirely. The same active ingredient at higher doses is sold as Wegovy, which is FDA-approved for chronic weight management.

Factor 3: Your deductible status. Most plans require you to meet a deductible before insurance starts paying. If your deductible is $3,000 and you have spent $0 on healthcare so far this year, your first Ozempic fill is full price. By the time you have spent $3,000, the lower copay kicks in.

Factor 4: Prior authorization (PA) status. Many plans cover Ozempic only with PA. Your provider submits documentation showing medical necessity (A1c, prior medication trials, BMI). PA approval takes 3 to 14 days. If PA is denied, you pay full cash price unless your provider appeals.

A 2024 GoodRx survey found 47% of new Ozempic prescriptions required a PA, and 22% of those PAs were denied on first submission.

For a deeper breakdown, see our Ozempic insurance overview.

The Novo Nordisk savings card: who qualifies, who does not

The Novo Nordisk savings card is manufacturer copay assistance for patients with commercial insurance using Ozempic for type 2 diabetes.

Eligibility:

• Commercial insurance covering Ozempic with any copay
• Ozempic prescribed for type 2 diabetes
• U.S. resident
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government-funded plan

Benefit:

• Copay reduced to as little as $25 per fill
• Maximum benefit of approximately $150 per fill (so if your copay is $300, you pay $150 after the card)
• Limited to 24 months of use total
• Maximum 24 fills

Excluded:

• Government insurance enrollees
• Patients whose plan does not cover Ozempic at all (the card reduces a copay; it does not replace coverage)
• Patients using Ozempic off-label

How to use it:

1. Download the card from the Novo Nordisk website or get a physical card from your provider.
2. Bring it to the pharmacy with your insurance card.
3. The pharmacist runs your insurance first, then applies the savings card.

About 20 to 25% of new Ozempic patients qualify for and use the card based on Novo Nordisk's own published statistics.

Medicare and Medicaid pricing

Medicare Part D: Plans cover Ozempic for type 2 diabetes with a typical specialty tier copay of $200 to $500 monthly. Medicare does not cover Ozempic for weight loss. The Inflation Reduction Act will renegotiate Part D pricing on Ozempic starting in 2027, which is expected to lower negotiated price meaningfully but is not yet in effect.

Medicare patients are not eligible for the Novo Nordisk savings card. This is the most common cost surprise for retirees who learn their Medicare Advantage plan covers Ozempic at $400 monthly and assume the savings card will help. It will not.

Medicaid: Coverage varies by state. Most state Medicaid programs cover Ozempic for type 2 diabetes with prior authorization, often at a $1 to $4 copay or no copay. Coverage for off-label weight loss is rare. About 38 states cover Ozempic for diabetes through Medicaid; 12 states have additional restrictions or do not cover it.

Dual-eligible (Medicare + Medicaid): Coverage usually defaults to Medicare Part D pricing, which means specialty tier copays apply. Some state programs offer additional cost-share reduction.

TRICARE: Covers Ozempic for type 2 diabetes through the TRICARE pharmacy benefit. Copay is $14 to $42 depending on plan and pharmacy. Off-label weight loss coverage is not provided.

VA: Covers Ozempic for type 2 diabetes through the VA pharmacy benefit at standard VA copays ($0 to $11 per fill).

The Patient Assistance Program for low-income patients

Novo Nordisk's NovoCare Patient Assistance Program (PAP) provides Ozempic free of charge to qualifying low-income patients.

Eligibility (as of 2026):

• Income below 400% of the federal poverty level (about $60,240 for an individual, $124,800 for a family of 4)
• U.S. resident or legal U.S. resident
• No prescription drug coverage, or coverage that does not cover Ozempic
• Prescription is for type 2 diabetes management

Benefit:

• Free Ozempic for up to 12 months at a time, renewable
• Shipped directly from Novo Nordisk to the patient's home
• No copay, no deductible, no insurance involvement

How to apply:

• Forms available on the NovoCare website
• Provider signs the medical necessity portion
• Approval typically takes 5 to 10 business days

The PAP is the most under-used assistance program for Ozempic. Many providers do not routinely mention it because the paperwork is provider-side. Patients who think they may qualify should ask their provider directly.

Compounded semaglutide as a cash-pay alternative

For patients without insurance coverage or without a viable copay, compounded semaglutide is the most common alternative.

Pricing:

• $179 to $349 per month through reputable online platforms
• $150 to $350 per month through local 503A compounding pharmacies
• Quarterly prepay discounts of 10 to 20% available on most platforms

Format:

• Multi-dose vial, drawn with a U-100 insulin syringe
• Dose flexibility (clinician can prescribe non-standard amounts)
• Some platforms include B12 in the formulation

Differences from brand-name Ozempic:

• Compounded semaglutide is not FDA-approved
• Prepared by a state-licensed 503A pharmacy in response to an individual prescription
• Has not undergone the FDA review process for safety, efficacy, or quality
• Not interchangeable with Ozempic in clinical or regulatory terms

For the full discussion of when compounded makes sense, see our compounded semaglutide article.

How to find your actual cost in 5 minutes

The easiest way to know what you will actually pay is to run a test claim before you fill.

Step 1: Open your insurance member portal or call the number on the back of the card. Search the formulary for "semaglutide" or "Ozempic." Note the tier, any prior authorization requirement, and any quantity limit.

Step 2: Call your preferred pharmacy. Give them your insurance information and ask them to run a "test claim" for Ozempic. They will return the exact copay before you fill anything. This is a free service.

Step 3: Compare against the savings card. If you have commercial insurance, download the Novo Nordisk savings card and ask the pharmacist to run both the insurance and the card together to see your card-applied price.

Step 4: Check GoodRx as a backup. If your insurance copay is higher than expected, GoodRx may beat it. Note that paying GoodRx instead of insurance does not count toward your deductible.

Step 5: If nothing is affordable, evaluate alternatives. Compounded semaglutide, Wegovy with a different prior authorization (if the indication is weight loss), or the Patient Assistance Program if income-eligible.

This 5-step verification, done before you fill, prevents the most common cost surprise (a $300 copay you were not expecting).

The five most common cost surprises

Surprise 1: The deductible has not been met. First-of-year fills frequently come back at full cash price because the patient has not met their deductible yet. The lower copay only kicks in once the deductible is satisfied.

Surprise 2: Prior authorization was not approved. A pharmacist runs the claim, the system returns "PA required," and the patient walks out with no medication. PA approval takes 3 to 14 days and requires the prescriber to submit documentation. Until PA is in place, the cash price applies.

Surprise 3: The plan covers Wegovy but not Ozempic for weight loss. Patients prescribed Ozempic off-label for weight loss often discover the denial only at the pharmacy counter. The fix is usually for the prescriber to switch the prescription to Wegovy if the indication is chronic weight management.

Surprise 4: Medicare patients trying to use the savings card. The card explicitly excludes government insurance enrollees. Medicare patients pay their full Part D specialty tier copay.

Surprise 5: Plan changes mid-year. Employer formularies sometimes change in January. A medication that was Tier 2 last year is Tier 3 this year. Patients fill in January expecting last year's copay and get a higher bill.

A simple habit prevents most of these: run a test claim with the pharmacy every January and after any insurance change, before filling.

FAQ

How expensive is Ozempic without insurance in 2026? Cash price runs $940 to $1,350 per month at major U.S. pharmacies. Costco members typically pay the lowest cash price ($895 to $1,025). With a GoodRx coupon, expect $850 to $1,075 depending on pharmacy and zip code.

How expensive is Ozempic with insurance? Typically $25 to $500 per month, depending on formulary tier, deductible status, and prior authorization. Most commercial plans place Ozempic on Tier 3 or specialty, which means $75 to $250 copays. With the Novo Nordisk savings card, eligible patients pay as little as $25.

Why is Ozempic so expensive? Three reasons: Novo Nordisk holds patents that block generic competition, semaglutide is a complex peptide that costs more to manufacture than a small molecule pill, and demand exceeded supply for years which removed any pressure to discount.

Does the Novo Nordisk savings card actually work? Yes, for eligible patients. Commercial insurance enrollees with Ozempic for type 2 diabetes can pay as little as $25 per fill. The card has a maximum benefit of approximately $150 per fill and a 24-month total use limit. Medicare and Medicaid patients are excluded.

How much does Ozempic cost on Medicare? Medicare Part D plans cover Ozempic for type 2 diabetes at specialty tier, typically $200 to $500 per month. Medicare does not cover Ozempic for weight loss. Medicare patients cannot use the Novo Nordisk savings card.

Is Ozempic cheaper at Costco or Walmart? Costco is usually $50 to $150 cheaper than Walmart for cash patients, but Costco requires a $60-plus annual membership. The savings on a single fill of Ozempic typically justifies the membership fee within one month.

Can I use GoodRx and insurance together for Ozempic? You can use either, but not both. If GoodRx is cheaper than your insurance copay, you can pay GoodRx instead. The GoodRx payment does not count toward your deductible.

Is compounded semaglutide cheaper than Ozempic? Yes, for patients without insurance or with high copays. Compounded semaglutide runs $179 to $349 per month against $940-plus cash for Ozempic. For patients with insurance and a low copay (under $100), brand-name Ozempic may be comparable or cheaper.

Does Walmart have a special Ozempic price? No. Walmart's pharmacy processes Ozempic through the same insurance pricing rules every other pharmacy uses. Walmart's cash price is competitive but not dramatically lower than CVS or Walgreens.

Will Ozempic prices drop in 2027? The Inflation Reduction Act will renegotiate Medicare Part D pricing on Ozempic starting in 2027, which is expected to reduce Medicare-negotiated price meaningfully. Commercial insurance pricing will likely follow but more slowly. Generic semaglutide is not expected before the early 2030s when patents expire.

How do I find out if my insurance covers Ozempic? Call the number on the back of your insurance card or log into the member portal. Search the formulary for "semaglutide" or "Ozempic." Note the tier, any prior authorization requirement, and any quantity limit. Then call your pharmacy to run a test claim.

What if I cannot afford Ozempic at any price? Three options: apply for the Novo Nordisk Patient Assistance Program (PAP) if your income is below 400% of the federal poverty level, ask your prescriber about Wegovy or Zepbound which may have different coverage, or consider compounded semaglutide as a cash-pay alternative.

Sources

1. Novo Nordisk. Ozempic prescribing information. Rev. 2024.
2. Novo Nordisk. Wholesale acquisition cost statement. NovoNordisk.com. 2024.
3. Tu HT, et al. International comparison of GLP-1 receptor agonist pricing. JAMA Netw Open. 2024.
4. GoodRx Research. Prior authorization survey on GLP-1 medications. GoodRx. 2024.
5. Centers for Medicare and Medicaid Services. Inflation Reduction Act drug price negotiation. CMS.gov. 2024.
6. Centers for Medicare and Medicaid Services. Medicare Part D coverage rules. CMS.gov. 2024.
7. Novo Nordisk. NovoCare Patient Assistance Program eligibility. NovoCare.com. 2024.
8. American Diabetes Association. Standards of Medical Care in Diabetes 2024.
9. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
10. Marso SP, et al. Semaglutide and cardiovascular outcomes (SUSTAIN-6). N Engl J Med. 2016;375:1834-1844.
11. Federal Register. Department of Health and Human Services Federal Poverty Guidelines. 2024.
12. National Association of Boards of Pharmacy. Verified Pharmacy Program data. NABP. 2024.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Walmart, CVS, Walgreens, Rite Aid, Costco, Sam's Club, HEB, GoodRx, and Mark Cuban Cost Plus Drugs are trademarks of their respective owners. Zepbound is a registered trademark of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.